S.Amdt. 2146Senate112th Congress (2011-2013)

To amend the Controlled Substances Act to place synthetic drugs in Schedule I.

What it does: Adds Subtitle D--Synthetic Drugs SECTION 1141. SHORT TITLE at the end of title XI
Submitted May 22, 2012

What it changes

1 change to S. 3187 · shown in the bill's text

Adds a section
  1. Adds Subtitle D--Synthetic Drugs SECTION 1141. SHORT TITLE at the end of title XI

    Adds a section

    In S. 3187 · Placed on Calendar Senate

    "(b) Financial Interest.--In this section, the term 'financial interest' means a financial interest under section 208(a) of title 18, United States Code.".

    Inserted: Subtitle D--Synthetic Drugs SECTION 1141. SHORT TITLE.

    Inserted: This subtitle may be cited as the "Synthetic Drug Abuse Prevention Act of 2012".

    Inserted: SEC. 1142. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT.

    Inserted: (a) Cannabimimetic Agents.--Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end the following:

    Inserted: "(d)(1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

    Inserted: "(2) In paragraph (1):

    Inserted: "(A) The term 'cannabimimetic agents' means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes:

    Inserted: "(i) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.

    Inserted: "(ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.

    Inserted: "(iii) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.

    Inserted: "(iv) 1-(1-naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.

    Inserted: "(v) 3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.

    Show 34 more inserted paragraphs

    Inserted: "(B) Such term includes--

    Inserted: "(i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP 47,497);

    Inserted: "(ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP 47,497 C8-homolog);

    Inserted: "(iii) 1-pentyl-3-(1-naphthoyl)indole (JWH 018 and AM678);

    Inserted: "(iv) 1-butyl-3-(1-naphthoyl)indole (JWH 073);

    Inserted: "(v) 1-hexyl-3-(1-naphthoyl)indole (JWH 019);

    Inserted: "(vi) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH 200);

    Inserted: "(vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH 250);

    Inserted: "(viii) 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH 081);

    Inserted: "(ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH 122);

    Inserted: "(x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH 398);

    Inserted: "(xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);

    Inserted: "(xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);

    Inserted: "(xiii) 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR 19 and RCS 4);

    Inserted: "(xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR 18 and RCS 8); and

    Inserted: "(xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH 203).".

    Inserted: (b) Other Drugs.--Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended in subsection (c) by adding at the end the following:

    Inserted: "(18) 4-methylmethcathinone (Mephedrone).

    Inserted: "(19) 3,4-methylenedioxypyrovalerone (MDPV).

    Inserted: "(20) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C E).

    Inserted: "(21) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C D).

    Inserted: "(22) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C C).

    Inserted: "(23) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C I).

    Inserted: "(24) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C T 2).

    Inserted: "(25) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C T 4).

    Inserted: "(26) 2-(2,5-Dimethoxyphenyl)ethanamine (2C H).

    Inserted: "(27) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C N).

    Inserted: "(28) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C P).".

    Inserted: SEC. 1143. TEMPORARY SCHEDULING TO AVOID IMMINENT HAZARDS TO PUBLIC SAFETY EXPANSION.

    Inserted: Section 201(h)(2) of the Controlled Substances Act (21 U.S.C. 811(h)(2)) is amended--

    Inserted: (1) by striking "one year" and inserting "2 years"; and

    Inserted: (2) by striking "six months" and inserting "1 year".

    Inserted: SEC. 1144. PROHIBITION ON IMPOSING MANDATORY MINIMUM SENTENCES.

    Inserted: Section 401(b)(1)(C) of the Controlled Substances Act (21 U.S.C. 841(b)(1)(C)) is amended by adding at the end the following: "Any mandatory minimum term of imprisonment required to be imposed under this subparagraph shall not apply with respect to any controlled substance added to schedule I by the Synthetic Drug Abuse Prevention Act of 2012.".

    Original wording

    At the end of title XI, insert the following:

Read automatically from the Congressional Record. Check the original before relying on it.

As printed

At the end of title XI, insert the following:

Subtitle D--Synthetic Drugs SECTION 1141. SHORT TITLE.

This subtitle may be cited as the “Synthetic Drug Abuse Prevention Act of 2012”.

SEC. 1142. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT.

(a) Cannabimimetic Agents.--Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end the following:

“(d)(1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

“(2) In paragraph (1):

“(A) The term ‘cannabimimetic agents' means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes:

“(i) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.

“(ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.

“(iii) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.

“(iv) 1-(1-naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.

“(v) 3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.

“(B) Such term includes--

“(i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP 47,497);

“(ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP 47,497 C8-homolog);

“(iii) 1-pentyl-3-(1-naphthoyl)indole (JWH 018 and AM678);

“(iv) 1-butyl-3-(1-naphthoyl)indole (JWH 073);

“(v) 1-hexyl-3-(1-naphthoyl)indole (JWH 019);

“(vi) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH 200);

“(vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH 250);

“(viii) 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH 081);

“(ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH 122);

“(x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH 398);

“(xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);

“(xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);

“(xiii) 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR 19 and RCS 4);

“(xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR 18 and RCS 8); and

“(xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH 203).”.

(b) Other Drugs.--Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended in subsection (c) by adding at the end the following:

“(18) 4-methylmethcathinone (Mephedrone).

“(19) 3,4-methylenedioxypyrovalerone (MDPV).

“(20) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C E).

“(21) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C D).

“(22) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C C).

“(23) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C I).

“(24) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C T 2).

“(25) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C T 4).

“(26) 2-(2,5-Dimethoxyphenyl)ethanamine (2C H).

“(27) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C N).

“(28) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C P).”.

SEC. 1143. TEMPORARY SCHEDULING TO AVOID IMMINENT HAZARDS TO PUBLIC SAFETY EXPANSION.

Section 201(h)(2) of the Controlled Substances Act (21 U.S.C. 811(h)(2)) is amended--

(1) by striking “one year” and inserting “2 years”; and

(2) by striking “six months” and inserting “1 year”.

SEC. 1144. PROHIBITION ON IMPOSING MANDATORY MINIMUM SENTENCES.

Section 401(b)(1)(C) of the Controlled Substances Act (21 U.S.C. 841(b)(1)(C)) is amended by adding at the end the following: “Any mandatory minimum term of imprisonment required to be imposed under this subparagraph shall not apply with respect to any controlled substance added to schedule I by the Synthetic Drug Abuse Prevention Act of 2012.”.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

4 earlier actions
Floor Latest Action

Senate amendment proposed (on the floor): Amendment SA 2146 proposed by Senator Harkin for Senator Portman.(consideration: CR S3545-3547, S3548-3550, S3555-3557)

May 24, 2012

View full timeline
Floor

Senate amendment proposed (on the floor): Amendment SA 2146 proposed by Senator Harkin for Senator Portman.(consideration: CR S3545-3547, S3548-3550, S3555-3557)

May 24, 2012

Floor

Senate amendment agreed to: Amendment SA 2146 as modified agreed to in Senate by Voice Vote.(text as modified: CR S3546)

May 24, 2012

Floor

Amendment SA 2146 proposed by Senator Harkin for Senator Portman. (consideration: CR S3545-3547, S3548-3550, S3555-3557) To amend the Controlled Substances Act to place synthetic drugs in Schedule I.

May 24, 2012

Floor

Amendment SA 2146 as modified agreed to in Senate by Voice Vote. (text as modified: CR S3546)

May 24, 2012

Floor

Senate amendment submitted

May 22, 2012